BBP-418 (Ribitol)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BBP-418 (Ribitol), covering 2025-09-29 to 2025-09-29. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Efficacy and Safety of BBP-418 (Ribitol) in Patients With Limb Girdle Muscular Dystrophy 2I (LGMD2I) [Phase 3]